OTCMKTS:ARNI Arno Therapeutics (ARNI) Stock Price, News & Analysis → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free ARNI Stock Alerts $0.0003 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.0003▼$0.000350-Day Range N/A52-Week Range$0.0001▼$0.0003VolumeN/AAverage Volume8,820 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings Get Arno Therapeutics alerts: Email Address Ad Porter & CompanyKiss of death from Joe BidenBiden cannot lose this election. A bombshell new documentary exposes how the D.C establishment has engineered an “electoral failsafe” that all but guarantees Democratic victory… not just in 2024 but every future election.I have uncovered a bombshell that changes everything… and threatens everything. About Arno Therapeutics Stock (OTCMKTS:ARNI)Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. was founded in 2005 and is based in Flemington, New Jersey.Read More ARNI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARNI Stock News HeadlinesMay 5, 2024 | msn.comFirefighters nationwide honor Jason Arno, over 200 others who lost their livesMay 1, 2024 | theguardian.comArno Penzias obituaryJune 18, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenBiden cannot lose this election. A bombshell new documentary exposes how the D.C establishment has engineered an “electoral failsafe” that all but guarantees Democratic victory… not just in 2024 but every future election.April 12, 2024 | msn.comFirst Firefighter Arno Memorial Foundation scholarship awardedMarch 1, 2024 | msn.comBuffalo to honor firefighter Jason Arno one year after his deathFebruary 29, 2024 | yahoo.comBuffalo to honor firefighter Jason Arno on one-year anniversary of his deathJanuary 28, 2024 | news.yahoo.comDr. Arno Penzias, physicist behind the Big Bang theory, dies at 90January 23, 2024 | msn.comNobel laureate Arno Penzias dies at 90; helped find traces of Big BangJune 18, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenBiden cannot lose this election. A bombshell new documentary exposes how the D.C establishment has engineered an “electoral failsafe” that all but guarantees Democratic victory… not just in 2024 but every future election.January 22, 2024 | nytimes.comArno A. Penzias, 90, Dies; Nobel Physicist Confirmed Big Bang TheoryJanuary 6, 2024 | nytimes.comArno J. Mayer, Unorthodox Historian of Europe’s Crises, Dies at 97October 10, 2023 | news.yahoo.comJason Arno among those honored at the New York State Fallen Firefighters Memorial CeremonyOctober 10, 2023 | msn.comJason Arno honored at NYS Fallen Firefighter Memorial CeremonySeptember 30, 2023 | msn.comBuffalo Fire dedicates engine truck that pays tribute to fallen firefighter Jason ArnoSeptember 29, 2023 | msn.comLawsuit filed against contractor tied to Main Street fire where firefighter Jason Arno diedSeptember 29, 2023 | news.yahoo.comBuffalo Fire Dept. dedicates new Engine 2 trucks to fallen firefighter Jason ArnoSeptember 29, 2023 | news.yahoo.comBuffalo Fire Dept. dedicates new Engine 2 trucks to fallen firefighter Jason ArnoSeptember 28, 2023 | msn.comEngine 2 dedicates new truck to Jason ArnoAugust 31, 2023 | msn.comNew Parks Police K9 named after Jason ArnoAugust 31, 2023 | msn.comArno makes his debut as newest NYS Park Police K-9August 30, 2023 | msn.comBuffalo Bisons $12 ticket game to benefit Firefighter Arno Memorial FundAugust 28, 2023 | msn.comFundraiser event held Sunday for new foundation set up in Jason Arno's memoryAugust 23, 2023 | msn.comBuffalo firefighter Jason Arno's legacy to be carried on with foundationJuly 22, 2023 | health.usnews.comMarjorie ArniJuly 21, 2023 | news.yahoo.com7 Investigates obtains ATF report from fire that killed Jason Arno in BuffaloJuly 14, 2023 | msn.comFirefighter Arno Memorial Foundation holding first fundraiser next monthJuly 14, 2023 | msn.comFirefighter Arno Memorial Foundation created in memory of fallen Buffalo firefighterSee More Headlines Receive ARNI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arno Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:ARNI CUSIP042564203 CIK1195116 Webwww.arnothera.com Phone(503) 598-6659FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. David M. Tanen J.D. (Age 51)Sec. Key Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors ARNI Stock Analysis - Frequently Asked Questions How have ARNI shares performed in 2024? Arno Therapeutics' stock was trading at $0.0001 at the beginning of 2024. Since then, ARNI shares have increased by 200.0% and is now trading at $0.0003. View the best growth stocks for 2024 here. What other stocks do shareholders of Arno Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Arno Therapeutics investors own include Ampliphi Biosciences (APHB), Achillion Pharmaceuticals (ACHN), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Abacus Property Group (ABP), Advanced BioMedical Technologies (ABMT), Abiomed (ABMD), ARCA biopharma (ABIO) and Abeona Therapeutics (ABEO). How do I buy shares of Arno Therapeutics? Shares of ARNI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ARNI) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredwhy 99.94% won’t make you moneyI believe there's only 5-7 stocks that you should trade in 2024. But here's the catch…because there's alway...Prosper Trading Academy | SponsoredThe Hidden Anchor Investment of the Elite RevealedThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because sav...Colonial Metals | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.